Results 251 to 260 of about 1,585,778 (337)

Identifying and Prioritizing Economic Opportunities for Medical Tourism Management: An Analytic Hierarchy process

Salman Abbasian‐Naghneh
openalex   +1 more source

Peer Review #1 of "Identifying suitable reference genes for gene expression analysis in developing skeletal muscle in pigs (v0.1)"

, 2016
Guanglin Niu, Yalan Yang, Yuanyuan Zhang, Chaoju Hua, Zishuai Wang, Zhonglin Tang, Kui Li, C Andersen, J Jensen, T Orntoft, M Blaha, L Nemcova, K Kepkova, P Vodicka, R Prochazka, C Boosani, K Dhar, S Bustin, H Cho, J Chung, K Song, K Noh, B Kim, E Chung, K Ylaya, J Kim, T Kim, S Hewitt, J Kim, Costa Junior, D Peixoto-Souza, F Araujo, P Barbalho-Moulin, M Alves, V Gomes, E, Costa, X Feng, Y Xiong, H Qian, M Lei, D Xu, Ren Zq, C Fonvig, E Chabanova, J Ohrt, L Nielsen, O Pedersen, T Hansen, H Thomsen, J Holm, J Gabert, E Beillard, Vhj Van Der Velden, W Bi, D Grimwade, N Pallisgaard, G Barbany, G Cazzaniga, J Cayuela, H Cave, F Pane, Jle Aerts, De Micheli, D Thirion, X Pradel, V Gonzalez, M Viehmann, S Malec, M Saglio, G Van Dongen, Jjm, D Ginzinger, R Hu, C Fan, H Li, Q Zhang, Y Fu, J Huggett, K Dheda, S Bustin, Zumla, R Huis, S Hawkins, G Neutelings, M Jain, A Nijhawan, A Tyagi, J Khurana, B Jian, B Liu, Y Bi, W Hou, C Wu, Han Tf, J Kim, H Cho, J Kim, S Hur, T Kim   +99 more
openalex   +2 more sources

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

Molecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande, Marcela de Oliveira Silva, Mariana Bisarro dos Reis, Rodrigo de Oliveira Cavagna, Luciane Sussuchi, Icaro Alves Pinto, Natalia Zampieri Pontes, Rodrigo Sampaio Chiarantano, Flavio Augusto Ferreira da Silva, Pedro de Marchi, Letícia Ferro Leal, Rui M. Reis   +11 more
wiley   +1 more source

Quantitative abundance and distribution data from the first systematic survey of alien invasive plants in the Xiaoxing'an Mountains, China (2022-2023). [PDF]

Biodivers Data J
Zhang Y, He Z, Dong X, Mu L, Wang H.
europepmc   +1 more source

Tumor Identifier Sponsor Defined Identifier [PDF]

, 2020
openaire   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

A taxonomically harmonized global dataset of wild bird hosts for avian influenza virus surveillance. [PDF]

Sci Data
Du F, Zhang Q, Cheng Y, Liu Y, Lei W, Wang L, Sun H, Sun Y, Liu J, Li Z, Pu J.   +10 more
europepmc   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

Conformational Preferences and Benchmarking of Computational Methods for Piperazine-Based Ligands. [PDF]

ACS Omega
Rincón DA, Zaorska E, Malinska M.
europepmc   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source